These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11496575)

  • 1. [Tumor markers in lung cancer].
    Gómez de Terreros Caro FJ; Alvarez-Sala Walther R; Prados Sánchez C; Díaz Ajero P
    An Med Interna; 2001 May; 18(5):289. PubMed ID: 11496575
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of serum markers in diagnosis and treatment monitoring in patients with lung cancer].
    Jassem E; Jassem J
    Przegl Lek; 1995; 52(8):392-4. PubMed ID: 8525011
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnostic value of combined detection of TPS, NSE and CEA in lung cancer].
    Zheng H; He BF; Luo RC
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):165-6. PubMed ID: 12581971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: a study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non-small cell lung cancer.
    Buccheri G; Ferrigno D
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):891-9. PubMed ID: 11689793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic markers for stage I non-small cell lung cancer.
    Mizuguchi S; Nishiyama N
    Lung Cancer; 2008 Feb; 59(2):274-5. PubMed ID: 18055061
    [No Abstract]   [Full Text] [Related]  

  • 6. [The diagnostic values of CA242 combining other tumor markers for lung cancer].
    Zhang S; Ma Y; Yang X
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):271-3. PubMed ID: 11775851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of determination of the serum carcinoembryonic antigen in oncopulmonology].
    Lazarev SM; Reshetov AV; Nikolaev GV; Volgin GN; Nokhrin AV; Kokorin DM
    Vestn Khir Im I I Grek; 2009; 168(3):21-5. PubMed ID: 19663274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lung cancer].
    Komagata H; Yoneda S
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1609-13. PubMed ID: 15508459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
    Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
    Pan QR; Zhang X; Xu ZF; Zheng S
    Ai Zheng; 2002 Feb; 21(2):196-9. PubMed ID: 12479076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tumor markers in lung cancer].
    Niho S; Shinkai T
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):2089-93. PubMed ID: 11791391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between serum carcinoembryonic antigen level and T status in non-small cell lung cancer.
    Tomita M; Matsuzaki Y; Shimizu T; Hara M; Ayabe T; Onitsuka T
    Anticancer Res; 2006; 26(5B):3845-8. PubMed ID: 17094411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of CEA, CYFRA 21-1, NSE and CA 125 assay in serum and pleural effusion of patients with lung cancer.
    Wu GP; Ba J; Zhao YJ; Wang EH
    Acta Cytol; 2007; 51(4):679-80. PubMed ID: 17718156
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic and prognostic importance of tumor markers in lung cancer.
    Ulsperger E; Karrer K
    Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):21-31. PubMed ID: 2545371
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of carcinoembryonic antigen in lung cancer using an immunoenzyme assay].
    Ial'chenko NA; Lagutin VD; Levik NN; Nekhaev OK
    Lab Delo; 1991; (6):36-8. PubMed ID: 1717751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of tumour and inflammatory markers in lung cancer.
    Oremek GM; Sauer-Eppel H; Bruzdziak TH
    Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment of a method to detect multiple antennae carcinoembryonic antigen (MA-CEA) and MA-CEA level in the sera of patients with malignant tumors].
    Zhang LJ; Liu SL; Xu SJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):734-6. PubMed ID: 15555448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of combined detection of tumor markers for the prediction of small cell and non-small cell lung cancer].
    Wu Y; Wu Y; Wang L; Qu L
    Wei Sheng Yan Jiu; 2000 Jul; 29(4):213-5. PubMed ID: 12520921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The function of the level of serum carcinoembryonic antigen on early recurrence of non-small cell lung cancer].
    Zhang ZF; Ma JQ; Sun N; Zhang L
    Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):817-9. PubMed ID: 15363304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.